Loading...
Loading...
Deutsche Bank raises its price target on Buy-rated Universal Health Services
UHS to $56, up $3.50, on model changes made ahead of earnings next week.
Deutsche Bank says, "Based on UHS' consistent commentary about acute care volumes and payor mix during 2H'2011, we believe it is prudent to trim Q4 estimates. Our changes are also reinforced by recent "equity in earnings" results from CYH's Q4, which provides some window into UHS' Las Vegas operations due to the UHS/CYH joint venture there. Our updated Q4 EPS is $0.86 down from prior $0.91 and flat sequentially with Q3'2011. Our Q4 EPS is slightly below the FactSet consensus of $0.90, while our FY 2011 EPS of $3.91 (from $3.96) is slightly below consensus of $3.96 but in-line with guidance of $3.85-$4.00."
UHS closed at $43.91 a share on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in